Bachem Holding AG
- BID
83.8
- ASK
84.15
- 404 Units165 Units
- 07/21, 18:09:57 PM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
21.37%
Market Cap
5.63 Bil.
P/E Ratio
30.18
Dividend Yield
1.50 %
Earnings per Share
2.12 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 83.75 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 06:02:29 PM | |
| DAILY VOLUME (UNITS) | 120 | |
| DAILY HIGH / LOW | 85.15 | 76.1 |
| PREV. DAY'S PRICE | 75.15 | (07/20) |
| CHANGE DAY BEFORE | +8.60 | 11.44 % |
| 52 WEEK HIGH / LOW | 90.25 (05/08) | 51.44 (11/20) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 1.54 | 1.68 | 2.12 | 2.52 | 3.26 |
DIVIDENDS PER SHARE | 0.82 | 0.89 | 0.96 | 1.08 | 1.19 |
DIVIDEND YIELD IN % | 1.23 % | 1.47 % | 1.50 % | - | - |
DIVIDEND GROWTH IN % | 10.20 % | 8.38 % | 7.81 % | - | - |
PRICE - EARNINGS RATIO | 43.40 | 36.10 | 30.18 | 30.60 | 23.68 |
PRICE - BOOK RATIO | 3.69 | 3.12 | 3.08 | - | - |
PRICE - SALES RATIO | 8.41 | 7.17 | 6.46 | - | - |
PRICE - CASH FLOW RATIO | 19.36 | 29.50 | 16.55 | - | - |
Master Data
| WKN | A3DLKE |
| ISIN | CH1176493729 |
| SYMBOL | BHM0 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Bachem |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Swiss Franc |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | 74.94 Mil. |
| MARKET CAPITALISATION | 5.63 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -5.59 % | 2.73 % | -0.33 % | 3.23 % | 21.37 % | - | - | 17.72 % |
| HIGH | 81.40 | 85.95 | 90.25 | 90.25 | 90.25 | - | - | 90.25 |
| LOW | 74.95 | 71.35 | 69.55 | 59.86 | 51.44 | - | - | 59.86 |
Dividende
pro Aktie
Company profile
Bachem Holding AG engages in the provision of peptides and oligonucleotides. It operates through the Europe/Asia and North America geographical segments. It offers project management, research grade production, catalog peptides, peptide NCES, and commercial NCES. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland.
Structured products for Bachem Holding AG
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.